485 related articles for article (PubMed ID: 23291034)
1. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
Abdou AG; Harba NM; Afifi AF; Elnaidany NF
Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
[TBL] [Abstract][Full Text] [Related]
2. The immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model.
Madbouly N; El Amir A; Abdel Kader A; Rabee I; Farid A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33625354
[No Abstract] [Full Text] [Related]
3. Effects of Enterococcus faecalis CECT 7121 on Cryptosporidium parvum infection in mice.
Del Coco VF; Sparo MD; Sidoti A; Santín M; Basualdo JA; Córdoba MA
Parasitol Res; 2016 Aug; 115(8):3239-44. PubMed ID: 27193238
[TBL] [Abstract][Full Text] [Related]
4. Effects of pine bark extract administered to immunosuppressed adult mice infected with Cryptosporidium parvum.
Kim HC; Healey JM
Am J Chin Med; 2001; 29(3-4):469-75. PubMed ID: 11789589
[TBL] [Abstract][Full Text] [Related]
5. Experimental infection with Cryptosporidium parvum IIaA21G1R1 subtype in immunosuppressed mice.
Del Coco VF; Córdoba MA; Sidoti A; Santín M; Drut R; Basualdo JA
Vet Parasitol; 2012 Dec; 190(3-4):411-7. PubMed ID: 22818787
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin repurposing for the treatment of cryptosporidiosis in experimentally immunosuppressed mice.
Madbouly Taha N; Salah A Yousof HA; El-Sayed SH; Younis AI; Ismail Negm MS
Exp Parasitol; 2017 Oct; 181():57-69. PubMed ID: 28764965
[TBL] [Abstract][Full Text] [Related]
7. Induction of Inflammatory Responses in Splenocytes by Exosomes Released from Intestinal Epithelial Cells following
Wang Y; Shen Y; Liu H; Yin J; Zhang XT; Gong AY; Chen X; Chen S; Mathy NW; Cao J; Chen XM
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642905
[No Abstract] [Full Text] [Related]
8. Role of wheat germ agglutinin (WGA) in treatment of experimental cryptosporidiosis.
Moustafa MA
J Egypt Soc Parasitol; 2003 Aug; 33(2):443-56. PubMed ID: 14964659
[TBL] [Abstract][Full Text] [Related]
9. [Protective effect of radix sophorae flavescentis mixture on intestinal mucosa in mice infected with Cryptosporidium parvum].
Ji R; Cui W; Liang RW; Guan ZY; Li RF
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Aug; 31(4):275-9. PubMed ID: 24812877
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the prophylactic and therapeutic effects of paromomycin, recombinant IL-12 alone or in combination against Cryptosporidium parvum infection in immunosuppressed mice.
Gamra MM; el-Hosseiny LM
J Egypt Soc Parasitol; 2003 Apr; 33(1):109-22. PubMed ID: 12739805
[TBL] [Abstract][Full Text] [Related]
11. Curcumin: A promising treatment for Cryptosporidium parvum infection in immunosuppressed BALB/c mice.
Asadpour M; Namazi F; Razavi SM; Nazifi S
Exp Parasitol; 2018 Dec; 195():59-65. PubMed ID: 30385266
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.
Asadpour M; Namazi F; Razavi SM; Nazifi S
Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627
[TBL] [Abstract][Full Text] [Related]
13. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
Morales Gomez MA
Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
[TBL] [Abstract][Full Text] [Related]
14. Concurrent response to challenge infection with Cryptosporidium parvum in immunosuppressed C57BL/6N mice.
Surl CG; Kim HC
J Vet Sci; 2006 Mar; 7(1):47-51. PubMed ID: 16434849
[TBL] [Abstract][Full Text] [Related]
15. Patent gut infections in immunosuppressed adult C57BL/6N mice following intraperitoneal injection of Cryptosporidium parvum oocysts.
Yang S; Healey MC
J Parasitol; 1994 Apr; 80(2):338-42. PubMed ID: 8158484
[TBL] [Abstract][Full Text] [Related]
16. Substance P receptor antagonism for treatment of cryptosporidiosis in immunosuppressed mice.
Robinson P; Martin P; Garza A; D'Souza M; Mastrangelo MA; Tweardy D
J Parasitol; 2008 Oct; 94(5):1150-4. PubMed ID: 18576802
[TBL] [Abstract][Full Text] [Related]
17. Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model.
Li X; Brasseur P; Agnamey P; Leméteil D; Favennec L; Ballet JJ; Rossignol JF
Folia Parasitol (Praha); 2003 Mar; 50(1):19-22. PubMed ID: 12735719
[TBL] [Abstract][Full Text] [Related]
18. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
[TBL] [Abstract][Full Text] [Related]
19. Adoptive transfer of immunity with intraepithelial lymphocytes in Cryptosporidium parvum-infected severe combined immunodeficient mice.
Adjei AA; Shrestha AK; Castro M; Enriquez FJ
Am J Med Sci; 2000 Nov; 320(5):304-9. PubMed ID: 11093682
[TBL] [Abstract][Full Text] [Related]
20. The suppressive effect of Mekabu fucoidan on an attachment of Cryptosporidium parvum oocysts to the intestinal epithelial cells in neonatal mice.
Maruyama H; Tanaka M; Hashimoto M; Inoue M; Sasahara T
Life Sci; 2007 Jan; 80(8):775-81. PubMed ID: 17157323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
